Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06615661 · ClinicalTrials.gov registry record
A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma
A clinical trial of Primary Open Angle Glaucoma (POAG), sponsored by Iantrek.
- Recruiting
- Registry status
- 200
- Enrollment target
- 2
- Study locations
NCT06615661 is a study of Primary Open Angle Glaucoma (POAG) that is actively recruiting participants, run by Iantrek. The registered enrollment target is 200 participants. The trial reports 2 study locations across 2 states.
The verdict
NCT06615661, a study of Primary Open Angle Glaucoma (POAG), is actively recruiting participants, sponsored by Iantrek.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and any device-related complications are collected during the study time period.
Conditions Studied
Interventions
- DEVICE C-Rex Instrument
Study Locations (2)
Georgia
- Omni Eye Services - Atlanta
Tennessee
- CIRCLE Site 04 - Crossville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-08-14 |
| Est. Completion | 2026-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06615661
The ClinicalTrials.gov registry entry for NCT06615661 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Iantrek, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Open Angle Glaucoma (POAG) appearing as the primary indexed condition, and to 1 intervention - of which C-Rex Instrument is the first listed.
NCT06615661 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Georgia, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06615661 about?
NCT06615661 is a clinical study titled "A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma". This study enrolls adults with primary open angle glaucoma (POAG) who underwent goniotomy intraocular pressure (IOP)-lowering surgery with the C-Rex Instrument. Patients are consented prior to surgery and followed for 12 months postoperatively. Data regarding IOP, use of glaucoma medications, and an...
What is the current status of trial NCT06615661?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-08-14. Estimated completion is 2026-10.
What conditions does trial NCT06615661 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma (POAG).
What interventions are being tested in trial NCT06615661?
The interventions under investigation include: C-Rex Instrument (DEVICE).
Who is sponsoring clinical trial NCT06615661?
This trial is sponsored by Iantrek, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06615661 being conducted?
This trial has 2 study locations across Georgia, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma (POAG)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.